Skip to main content
OpenTrials
Completed

NCT Number: NCT03851328

Best Possible Medication History at USB

This pilot project investigates the use of a structured medication history (Best Possible Medication History, BPMH) in patients (primarily admitted at the emergency department of University Hospital Basel) after transfer to a medical ward. Unintentional medication discrepancies are analyzed comparing outpatient and inpatient medication therapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Best Possible Medication History Chemically-Induced Disorders Drug-Related Side Effects and Adverse Reactions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Spitalpharmazie Universitätsspital Basel (USB)

Basel, 4031, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Admission to Emergency Department of University Hospital Basel and transfer to medical ward

Exclusion criteria

  • medication history taken at Emergency Department of University Hospital Basel not present

Treatment and study plan

BPMH structured interview

Other

creating a standardized medication list by interviewing patient and/ or relatives according to Best Possible Medication History (BPMH) after patient transfer to medical ward

Primary outcomes

  1. unintended medication discrepancy

    Time frame: single time point (1 day after admission to hospital)

    number of unintended medication discrepancies comparing medication history taken when admitted to emergency department and BPMH after transfer to medical ward

Secondary outcomes

  1. Categorisation ( Class1, Class2, Class3) for clinical relevance of unintended medication discrepancy

    Time frame: during 7 days after admission to hospital

    expert panel classifies each unintended medication discrepancy in 1 of 3 classes for its potential to cause patient harm. Class 1 discrepancies are those unlikely to cause patient discomfort or clinical deterioration. Class 2 discrepancies could potentially result in moderate discomfort or clinical deterioration. Class 3 discrepancies could potentially result in severe discomfort or clinical deterioration.

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Official study title

Best Possible Medication History at Universitätsspital Basel (USB)

Acronym: bpmh@USB

Important dates

Study start
2017
Primary completion
2017
Study completion
2019
First posted
Feb 22, 2019
Registry last updated
May 6, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.